Expression of granzyme B by cytotoxic T lymphocytes in the lymph nodes of HIV-infected patients. 1997

G Koopman, and P C Wever, and M D Ramkema, and F Bellot, and P Reiss, and R M Keehnen, and I J Ten Berge, and S T Pals
Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands.

During HIV infection the architecture of secondary lymphoid tissues is severely disrupted. In particular the germinal centers, which play a key role in the orchestration of the secondary immune response, undergo gross phenotypic alterations, leading to a complete destruction of the germinal center microenvironment. The precise mechanisms responsible for the lymphoid tissue destruction in HIV infection are still unknown. However, the large influx of CD8+ T lymphocytes suggests an important role for T cell-mediated cytotoxicity. To establish whether the infiltrating CD8+ T lymphocytes are killing competent, we investigated the expression of granzyme B, which is known to be present in the cytotoxic granules of NK cells and "activated" CTLs with cytolytic potential. We observed a 20-fold increase in the percentage of granzyme B-expressing CD8+ T cells in both the germinal center and the interfollicular areas in HIV patients relative to HIV-negative controls. This increase was present in patients with early-stage disease (i.e., absolute CD4+ T cell count > 500/microliters) as well as in patients with intermediate and late-stage disease. Thus, from relatively early stages of HIV infection onward large numbers of killing competent T lymphocytes are present in the lymphoid tissues, a finding that supports the notion that CTL act as mediators of destruction of immune function during HIV infection.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007223 Infant A child between 1 and 23 months of age. Infants
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012697 Serine Endopeptidases Any member of the group of ENDOPEPTIDASES containing at the active site a serine residue involved in catalysis. Serine Endopeptidase,Endopeptidase, Serine,Endopeptidases, Serine

Related Publications

G Koopman, and P C Wever, and M D Ramkema, and F Bellot, and P Reiss, and R M Keehnen, and I J Ten Berge, and S T Pals
July 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
G Koopman, and P C Wever, and M D Ramkema, and F Bellot, and P Reiss, and R M Keehnen, and I J Ten Berge, and S T Pals
February 2005, Virology,
G Koopman, and P C Wever, and M D Ramkema, and F Bellot, and P Reiss, and R M Keehnen, and I J Ten Berge, and S T Pals
January 2021, Methods in molecular biology (Clifton, N.J.),
G Koopman, and P C Wever, and M D Ramkema, and F Bellot, and P Reiss, and R M Keehnen, and I J Ten Berge, and S T Pals
September 1991, AIDS (London, England),
G Koopman, and P C Wever, and M D Ramkema, and F Bellot, and P Reiss, and R M Keehnen, and I J Ten Berge, and S T Pals
May 2009, Journal of immunology (Baltimore, Md. : 1950),
G Koopman, and P C Wever, and M D Ramkema, and F Bellot, and P Reiss, and R M Keehnen, and I J Ten Berge, and S T Pals
December 1982, Immunology today,
G Koopman, and P C Wever, and M D Ramkema, and F Bellot, and P Reiss, and R M Keehnen, and I J Ten Berge, and S T Pals
January 1997, Histopathology,
G Koopman, and P C Wever, and M D Ramkema, and F Bellot, and P Reiss, and R M Keehnen, and I J Ten Berge, and S T Pals
January 2004, Otolaryngologia polska = The Polish otolaryngology,
G Koopman, and P C Wever, and M D Ramkema, and F Bellot, and P Reiss, and R M Keehnen, and I J Ten Berge, and S T Pals
January 1990, Research in virology,
G Koopman, and P C Wever, and M D Ramkema, and F Bellot, and P Reiss, and R M Keehnen, and I J Ten Berge, and S T Pals
July 1994, Nature,
Copied contents to your clipboard!